Corebridge Financial (NYSE:CRBG) reported quarterly earnings of $0.57 per share which beat the analyst consensus estimate of $0.49 by 16.33 percent.
XORTX Therapeutics Announces 1-For-9 Share Consolidation
XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU)))), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease,
